Based on the Tevogen Bio Holdings Inc stock forecast from 0 analysts, the average analyst target price for Tevogen Bio Holdings Inc is not available over the next 12 months. Tevogen Bio Holdings Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Tevogen Bio Holdings Inc is Slightly Bearish, which is based on 3 positive signals and 4 negative signals. At the last closing, Tevogen Bio Holdings Inc’s stock price was USD 1.23. Tevogen Bio Holdings Inc’s stock price has changed by +6.96% over the past week, +26.93% over the past month and +50.00% over the last year.
No recent analyst target price found for Tevogen Bio Holdings Inc
No recent average analyst rating found for Tevogen Bio Holdings Inc
Company Overview Tevogen Bio Holdings Inc
Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients. It is also developing TVGN 920 for treating cervical cancer; TVGN 960 for treating oropharyngeal cancer; TVGN 601 for treating MS; and TVGN 930 for treating EBV-associated lymphomas. The company was founded in 2020 and is headquartered in Warren, New Jersey. Read Less
Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the...Read More
Frequently Asked Questions About Tevogen Bio Holdings Inc (TVGN) Stock
Stock Target Advisor's fundamental analysis for Tevogen Bio Holdings Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on TVGN's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on TVGN's stock to indicate what its average analyst target is.
TVGN stock's Price/Earning ratio is 3.66.
Our analysis grades TVGN stock's Price / Earning ratio at F. This means that TVGN stock's Price/Earning ratio is above 43.00000000000001% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this TVGN may be fairly valued for its sector
The last closing price of TVGN's stock was USD 1.23.
The most recent market capitalization for TVGN is USD 0.21B.
Unfortunately we do not have enough analyst data on TVGN's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Tevogen Bio Holdings Inc's stock.
As per our most recent records Tevogen Bio Holdings Inc has 18 Employees.
Tevogen Bio Holdings Inc's registered address is 15 Independence Boulevard, Warren, NJ, United States, 07059.
You can get more information about it from Tevogen Bio Holdings Inc's website at https://tevogen.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Tevogen Bio Holdings Inc (TVGN) Stock
Stock Target Advisor's fundamental analysis for Tevogen Bio Holdings Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on TVGN's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on TVGN's stock to indicate what its average analyst target is.
TVGN stock's Price/Earning ratio is 3.66.
Our analysis grades TVGN stock's Price / Earning ratio at F. This means that TVGN stock's Price/Earning ratio is above 43.00000000000001% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this TVGN may be fairly valued for its sector
The last closing price of TVGN's stock was USD 1.23.
The most recent market capitalization for TVGN is USD 0.21B.
Unfortunately we do not have enough analyst data on TVGN's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Tevogen Bio Holdings Inc's stock.
As per our most recent records Tevogen Bio Holdings Inc has 18 Employees.
Tevogen Bio Holdings Inc's registered address is 15 Independence Boulevard, Warren, NJ, United States, 07059.
You can get more information about it from Tevogen Bio Holdings Inc's website at https://tevogen.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for TVGN !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
